Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 379.90K | 380.20K | -399.20K | -398.30K | -328.00K |
| Total Depreciation and Amortization | 182.70K | 182.80K | 244.90K | 244.30K | 79.20K |
| Total Amortization of Deferred Charges | -46.50K | -46.60K | -- | -- | 146.00K |
| Total Other Non-Cash Items | -595.40K | -595.90K | 463.60K | 462.50K | -1.09M |
| Change in Net Operating Assets | -1.34M | -1.34M | -847.30K | -845.30K | 799.50K |
| Cash from Operations | -1.42M | -1.42M | -538.00K | -536.70K | -388.80K |
| Capital Expenditure | -132.80K | -132.90K | -24.30K | -24.20K | -11.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 230.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 63.60K | 63.70K | 39.00K | 39.00K | 40.50K |
| Cash from Investing | -69.20K | -69.20K | 14.70K | 14.70K | 259.10K |
| Total Debt Issued | 1.51M | 1.51M | 2.77M | 2.77M | 608.50K |
| Total Debt Repaid | -2.94M | -2.94M | -265.00K | -265.00K | -265.00K |
| Issuance of Common Stock | 13.44M | 13.44M | 6.67M | 6.67M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -311.00K | -311.00K | -172.00K | -172.00K | -119.50K |
| Cash from Financing | 1.50M | 1.51M | 1.15M | 1.15M | 28.60K |
| Foreign Exchange rate Adjustments | 205.90K | 206.00K | -214.90K | -214.40K | -112.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.70K | 218.90K | 415.80K | 414.80K | -214.00K |